MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
MacroGenics (MGNX) PT Lowered to $6 at Stifel
August 7, 2024 10:18 AM EDTStifel analyst Stephen Willey lowered the price target on MacroGenics (NASDAQ: MGNX) to $6.00 (from $7.00) while maintaining a Hold rating.
The analyst comments "Our Hold-rated thesis on MGNX shares remains unchanged following managements earnings announcement and corporate update. While the presentation of... More



